TEM Rebounds on "Xm" News: Can Stock Return to $70?

Tempus AI surged over 8% intraday against the market trend after the company launched Xm, a test designed to monitor immunotherapy responses in patients with advanced cancer. TEM's stock price fell 20% last week after being targeted by a short report from Spruce Point. The report raised serious concerns about the integrity of Tempus AI's products, the credibility of its management team, and its financial reporting practices. ------- How do you view the rally after the short report? Did you buy the dip last week? Will you sell to take profit now or hold?

avatarThe Catalist
2025-06-06

Tempus AI: Full power, but fuel burn is still high – A fresh look after Q1-25 and the Ambry bolt-on

$Tempus AI(TEM)$ Where Data-Rich Precision Medicine Meets Scalable AI Source: Tempus AI Q1 Investor Presentation: Summary Tempus AI is a Chicago-based health-tech company on a mission to make every cancer diagnosis—and eventually every serious disease—an algorithmically informed decision. The firm combines high-throughput genomic testing with one of the world’s largest, fully-consented clinical-outcomes databases. By structuring 40-plus million patient records into a searchable, machine-learning platform, Tempus gives oncologists and drug developers real-time insight into which therapies work, why they work, and for whom. Dual-engine model – Tempus runs CLIA-certified labs that process hundreds of thousands of DNA/RNA samples a year, generating ste
Tempus AI: Full power, but fuel burn is still high – A fresh look after Q1-25 and the Ambry bolt-on

Nancy Pelosi's Tempus' AI Boost: New Product & AI Helpers

$Tempus AI(TEM)$ is up 15% after launching AI agents directly into Electronic Healthcare Records (EHRs).Why did the $Tempus AI(TEM)$ price go up?The new test is a game-changer: Tempus came out with this cool new test called xM. It’s like a super-smart way to monitor how cancer patients are responding to immunotherapy. Instead of waiting for symptoms to show up, doctors can get early insights into what’s happening with the cancer cells just by analyzing a blood sample. This helps them tweak treatments way ahead of time. The market loves this kind of innovation, so investors got excited and the stock price jumped.AI is now in hospitals: Tempus embedded over 1,000 AI helpers directly into hospital electronic heal
Nancy Pelosi's Tempus' AI Boost: New Product & AI Helpers
avatarArianda
2025-06-03
$Tempus AI(TEM)$  Tempus AI’s recent 8% intraday rally following the launch of their new Xm test shows that investors are optimistic about the potential of this tool to monitor immunotherapy responses in advanced cancer patients. This kind of innovation could drive significant growth if the test proves effective and gains adoption, which explains the positive market reaction despite recent challenges. However, the short report from Spruce Point last week, which led to a 20% drop in TEM’s stock, raises serious concerns about the company’s product integrity, management credibility, and financial transparency. These issues can’t be ignored, as they pose real risks to the company’s long-term prospects. The rally could be a short-term rebound fuele
avatarBABY SPACEROCK
2025-06-03
$Tempus AI(TEM)$  not sure what TEM is, what's your opinion on this stock? Come comment for coins @mary__  @LULU ROCKET  @JiaDeName  @Mr_Hotpot  @Billion  
avatarVaz000
2025-06-02
avatar大眼仔003
2025-06-04
$Tempus AI(TEM)$  [得意]  
avatarbb96
2025-06-05